Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts.

Cockfield SM, Wilson S, Campbell PM, Cantarovich M, Gangji A, Houde I, Jevnikar AM, Keough-Ryan TM, Monroy-Cuadros FM, Nickerson PW, Pâquet MR, Ramesh Prasad GV, Senécal L, Shoker A, Wolff JL, Howell J, Schwartz JJ, Rush DN.

Am J Transplant. 2019 Jun;19(6):1730-1744. doi: 10.1111/ajt.15225. Epub 2019 Feb 1.

2.

Organ donor management and delayed graft function in kidney transplant recipients: A multicenter retrospective cohort study.

Cardinal H, Lamarche F, Grondin S, Marsolais P, Lagacé AM, Duca A, Albert M, Houde I, Boucher A, Masse M, Baran D, Bouchard J.

Am J Transplant. 2019 Jan;19(1):277-284. doi: 10.1111/ajt.15127. Epub 2018 Oct 29.

PMID:
30253052
3.

A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients.

Hosseini-Moghaddam SM, Shokoohi M, Singh G, Dufresne SF, Boucher A, Jevnikar A, Prasad GVR, Shoker A, Kabbani D, Hebert MJ, Cardinal H, Houde I, Humar A, Kumar D.

Clin Infect Dis. 2019 Apr 8;68(8):1320-1326. doi: 10.1093/cid/ciy682.

PMID:
30107568
4.

Impact of the Current Versus the Previous Diagnostic Threshold on the Outcome of Patients With Borderline Changes Suspicious for T Cell-mediated Rejection Diagnosed on Indication Biopsies.

McRae M, Bouchard-Boivin F, Béland S, Noël R, Côté I, Lapointe I, Lesage J, Latulippe E, Riopel J, Santoriello D, Husain SA, Désy O, Houde I, Batal I, De Serres SA.

Transplantation. 2018 Dec;102(12):2120-2125. doi: 10.1097/TP.0000000000002327.

PMID:
29916985
5.

Impaired Secretion of TNF-α by Monocytes Stimulated With EBV Peptides Associates With Infectious Complications After Kidney Transplantation.

Vallin P, Désy O, Béland S, Bouchard-Boivin F, Houde I, De Serres SA.

Transplantation. 2018 Jun;102(6):1005-1013. doi: 10.1097/TP.0000000000002133.

PMID:
29470349
6.

Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study.

Béland MA, Lapointe I, Noël R, Côté I, Wagner E, Riopel J, Latulippe E, Désy O, Béland S, Magee CN, Houde I, De Serres SA.

Transpl Int. 2017 May;30(5):502-509. doi: 10.1111/tri.12934. Epub 2017 Mar 5.

7.

2013 Banff Criteria for Chronic Active Antibody-Mediated Rejection: Assessment in a Real-Life Setting.

De Serres SA, Noël R, Côté I, Lapointe I, Wagner E, Riopel J, Latulippe E, Agharazii M, Houde I.

Am J Transplant. 2016 May;16(5):1516-25. doi: 10.1111/ajt.13624. Epub 2016 Jan 14.

8.

Kidney Paired Donation Protocol for Participating Donors 2014.

Richardson R, Connelly M, Dipchand C, Garg AX, Ghanekar A, Houde I, Johnston O, Mainra R, McCarrell R, Mueller T, Nickerson P, Pippy C, Storsley L, Tinckam K, Wright L, Yilmaz S, Landsberg D; Protocols Working Group of the Canadian Blood Services’ Living Donation Advisory Committee.

Transplantation. 2015 Oct;99(10 Suppl 1):S1-S88. doi: 10.1097/TP.0000000000000918. No abstract available.

PMID:
26425842
9.

Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy.

Lesage J, Noël R, Lapointe I, Côté I, Wagner E, Désy O, Caumartin Y, Agharazii M, Batal I, Houde I, De Serres SA.

Transplantation. 2015 Jan;99(1):69-76. doi: 10.1097/TP.0000000000000310.

PMID:
25073036
10.

The interpretation of repeat renal biopsies in patients with lupus nephritis.

McRae M, Rousseau-Gagnon M, Philibert D, Houde I, Riopel J, Latulippe E, De Serres SA.

Rheumatology (Oxford). 2014 Jun;53(6):1151-2. doi: 10.1093/rheumatology/ket420. Epub 2013 Dec 20. No abstract available.

PMID:
24361694
11.

Impact of donor age on long-term outcomes after delayed graft function: 10-year follow-up.

Lapointe I, Lachance JG, Noël R, Côté I, Caumartin Y, Agharazii M, Houde I, Rousseau-Gagnon M, Kim SJ, De Serres SA.

Transpl Int. 2013 Feb;26(2):162-9. doi: 10.1111/tri.12016. Epub 2012 Dec 1.

12.

Dual-kidney transplants as an alternative for very marginal donors: long-term follow-up in 63 patients.

De Serres SA, Caumartin Y, Noël R, Lachance JG, Côté I, Naud A, Fradet Y, Mfarrej BG, Agharazii M, Houde I.

Transplantation. 2010 Nov 27;90(10):1125-30. doi: 10.1097/TP.0b013e3181f8f2b8.

PMID:
20921934
13.

Age-related and blood pressure-independent reduction in aortic stiffness after kidney transplantation.

Ignace S, Utescu MS, De Serres SA, Marquis K, Gaudreault-Tremblay MM, Larivière R, Côté I, Houde I, Lebel M, Agharazii M.

J Hypertens. 2011 Jan;29(1):130-6. doi: 10.1097/HJH.0b013e32833f5e68.

PMID:
20852446
14.

The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation.

Gourishankar S, Houde I, Keown PA, Landsberg D, Cardella CJ, Barama AA, Dandavino R, Shoker A, Pirc L, Wrobel MM, Kiberd BA.

Clin J Am Soc Nephrol. 2010 Jul;5(7):1282-9. doi: 10.2215/CJN.09091209. Epub 2010 May 24.

15.

Pulmonary recruitment protocol for organ donors: a new strategy to improve the rate of lung utilization.

Noiseux N, Nguyen BK, Marsolais P, Dupont J, Simard L, Houde I, Lallier M, Langevin S, Cantin B, Ferraro P.

Transplant Proc. 2009 Oct;41(8):3284-9. doi: 10.1016/j.transproceed.2009.08.041.

PMID:
19857731
16.

Screening for polyomavirus associated nephropathy in renal transplantation with blood viral load measurement.

Boudreault AA, Courtemanche C, Latulippe E, Côté I, Houde I, Deschênes L.

J Clin Virol. 2009 Aug;45(4):318-21. doi: 10.1016/j.jcv.2009.05.025. Epub 2009 Jun 25.

PMID:
19559645
17.

Modifiable factors predicting patient survival in elderly kidney transplant recipients.

Cardinal H, Hébert MJ, Rahme E, Houde I, Baran D, Masse M, Boucher A, Le Lorier J; Elderly Recipients Transplant Group.

Kidney Int. 2005 Jul;68(1):345-51.

18.

Endothelin-1 levels and cardiovascular risk factors in renal transplant patients.

Radeau T, Lebel M, Houde I, Larivière R, Mauriège P, Kingma I, Lachance JG, Noël R, Després JP, Bergeron J.

Clin Biochem. 2004 Dec;37(12):1072-8.

PMID:
15589812
20.

Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients.

Lemieux I, Houde I, Pascot A, Lachance JG, Noël R, Radeau T, Després JP, Bergeron J.

Kidney Int. 2002 Nov;62(5):1839-47.

21.

New immunosuppressive regimens and cytomegalovirus infection after kidney transplantation: a retrospective study.

Côté I, Deschêsnes L, de Cotret PR, Lachance JG, Noël R, Isenring P, Houde I.

Transplant Proc. 2001 Nov-Dec;33(7-8):3626-9. No abstract available.

PMID:
11750540
22.

Mycophenolate mofetil, an alternative to cyclosporine A for long-term immunosuppression in kidney transplantation?

Houde I, Isenring P, Boucher D, Noël R, Lachanche JG.

Transplantation. 2000 Oct 27;70(8):1251-3.

PMID:
11063351
23.

Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection.

Dugré FJ, Gaudreau S, Belles-Isles M, Houde I, Roy R.

Transplantation. 2000 Oct 15;70(7):1074-80.

PMID:
11045645
24.

HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.

Radeau T, Vohl MC, Houde I, Lachance JG, Noël R, Després JP, Douville P, Bergeron J.

Nephron. 2000 Apr;84(4):333-41.

PMID:
10754410
25.

Characterization of two polymorphic sites in the human kinin B1 receptor gene: altered frequency of an allele in patients with a history of end-stage renal failure.

Bachvarov DR, Landry M, Pelletier I, Chevrette M, Betard C, Houde I, Bergeron J, Lebel M, Marceau F.

J Am Soc Nephrol. 1998 Apr;9(4):598-604.

26.

Monitoring of cytomegalovirus infections by the CD8+CD38+ T-cell subset in kidney transplant recipients.

Belles-Isles M, Houde I, Lachance JG, Noël R, Kingma I, Roy R.

Transplantation. 1998 Jan 27;65(2):279-82.

PMID:
9458031
28.
29.

Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors.

Davodeau F, Peyrat MA, Hallet MM, Gaschet J, Houde I, Vivien R, Vie H, Bonneville M.

J Immunol. 1993 Aug 1;151(3):1214-23.

PMID:
8393042
30.

Secretion of disulfide-linked human T-cell receptor gamma delta heterodimers.

Davodeau F, Houde I, Boulot G, Romagné F, Necker A, Canavo N, Peyrat MA, Hallet MM, Vié H, Jacques Y, et al.

J Biol Chem. 1993 Jul 25;268(21):15455-60.

31.

Surface expression of two distinct functional antigen receptors on human gamma delta T cells.

Davodeau F, Peyrat MA, Houde I, Hallet MM, De Libero G, Vié H, Bonneville M.

Science. 1993 Jun 18;260(5115):1800-2.

PMID:
8390096
32.

Peripheral selection of antigen receptor junctional features in a major human gamma delta subset.

Davodeau F, Peyrat MA, Hallet MM, Houde I, Vie H, Bonneville M.

Eur J Immunol. 1993 Apr;23(4):804-8.

PMID:
8384559

Supplemental Content

Support Center